- Home
- NKTR vs SMTI Comparison
NKTR vs SMTI Comparison
Compare NKTR & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- SMTI
- Stock Information
- Founded
- NKTR 1990
- SMTI 1982
- Country
- NKTR United States
- SMTI United States
- Employees
- NKTR N/A
- SMTI N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- NKTR Health Care
- SMTI Health Care
- Exchange
- NKTR Nasdaq
- SMTI Nasdaq
- Market Cap
- NKTR 108.3M
- SMTI 252.1M
- IPO Year
- NKTR 1994
- SMTI N/A
- Fundamental
- Price
- NKTR $24.25
- SMTI $29.84
- Analyst Decision
- NKTR Strong Buy
- SMTI Strong Buy
- Analyst Count
- NKTR 6
- SMTI 2
- Target Price
- NKTR $81.67
- SMTI $49.50
- AVG Volume (30 Days)
- NKTR 4.8M
- SMTI 51.0K
- Earning Date
- NKTR 08-07-2025
- SMTI 08-11-2025
- Dividend Yield
- NKTR N/A
- SMTI N/A
- EPS Growth
- NKTR N/A
- SMTI N/A
- EPS
- NKTR N/A
- SMTI N/A
- Revenue
- NKTR $87,248,000.00
- SMTI $91,569,883.00
- Revenue This Year
- NKTR N/A
- SMTI $23.53
- Revenue Next Year
- NKTR N/A
- SMTI $5.93
- P/E Ratio
- NKTR N/A
- SMTI N/A
- Revenue Growth
- NKTR N/A
- SMTI 34.65
- 52 Week Low
- NKTR $6.48
- SMTI $25.86
- 52 Week High
- NKTR $37.38
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- NKTR 63.40
- SMTI 53.37
- Support Level
- NKTR $21.87
- SMTI $29.80
- Resistance Level
- NKTR $26.59
- SMTI $30.94
- Average True Range (ATR)
- NKTR 4.14
- SMTI 1.07
- MACD
- NKTR 0.01
- SMTI 0.29
- Stochastic Oscillator
- NKTR 54.77
- SMTI 73.17
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.